Report Overview

The EU Ulcerative Colitis market size stood at around USD $1.39 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Ulcerative Colitis is an inflammatory bowel disease that results in ulcers and inflammation of the rectum and colon. The disease usually lasts long term and the symptoms include diarrhea with blood and abdominal pain. It can also result in inflammations in several body parts and can also lead to colon cancer



Market Drivers

The number of patients suffering from ulcerative colitis is increasing from the past few years which is certainly a major factor driving the demand of the market. Increasing stress levels among individuals and the adoption of an unhealthy diet are also some of the common factors for the growth of the ulcerative colitis market in Europe. Awareness over the symptoms of the disease in the early stage is also propelling the demand of the market as an early diagnosis of any disease may have a permanent cure. Increasing support from the government and non-government agencies is also accelerating the demand for the ulcerative colitis market in Europe